Surgery and Intrapleural Docetaxel in Treating Patients With Malignant Pleural Effusion

Completed · Phase 1

Conditions studied: Metastatic Cancer

In brief

RATIONALE: Giving drugs, such as docetaxel, directly into the pleura after surgery to drain the pleural effusion may help keep fluid from building up again. PURPOSE: This phase I trial is studying the side effects, best way to give, and best dose of intrapleural docetaxel given after surgery in patients with malignant pleural effusion.

Key facts

Study ID

NCT00114205

Run by

University of Virginia

People needed

24

Starts

2003-07-01

Last updated by the study team

2010-03-18

Who can join

Age: 18 and older. Sex: any. Healthy volunteers: not accepted.

Where it is running

• University of Virginia Cancer Center — Charlottesville, Virginia, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.